Feedback / Questions
LUT014 - Lutris Pharma
https://www.prnewswire.com/news-releases/lutris-pharma-receives-fda-orphan-drug-designation-for-lut014-for-the-treatment-of-egfri-induced-acneiform-rash-302073499.html
Feb 28, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next